MedTrace Logo

ED90 of Remimazolam Anesthesia Induction in Painless Bidirectional Endoscopy in Children

NCT06121609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2025-12-02

Study results available
· View outcomes & findings →

Summary

Exploring the ED90 of remimazolam in pediatric bidirectional endoscopy at different age groups.

Conditions

  • Bidirectional Endoscopy

Interventions

DRUG

Remimazolam

Exploring ED90 induced by remimazolam anesthesia in children of different age groups undergoing painless bidirectional endoscopy

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • aihua Du, Dr. · Tongji Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2024-04-30
Completion
2024-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06121609 on ClinicalTrials.gov